학술논문
Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison.
Document Type
Article
Author
Hoogland, Aasha I.; Small, Brent J.; Oswald, Laura B.; Bryant, Crystal; Rodriguez, Yvelise; Gonzalez, Brian D.; Li, Xiaoyin; Janelsins, Michelle C.; Bulls, Hailey W.; James, Brian W.; Arboleda, Bianca; Colon-Echevarria, Claudia; Townsend, Mary K.; Tworoger, Shelley S.; Rodriguez, Paulo C.; Bower, Julienne E.; Apte, Sachin M.; Wenham, Robert M.; Jim, Heather S. L.
Source
Subject
*BIOMARKERS
*INFLAMMATION
*SELF-evaluation
*CANCER chemotherapy
*CANCER patients
*COMPARATIVE studies
*SLEEP
*DESCRIPTIVE statistics
*TUMOR necrosis factors
*MENTAL depression
*RESEARCH funding
*FATIGUE (Physiology)
*FEMALE reproductive organ tumors
*DISEASE complications
*SYMPTOMS
*
*
*
*
*
*
*
*
*
*
*
*
*
*
Language
ISSN
2072-6694
Abstract
Simple Summary: Treatment-related symptoms such as fatigue, depression, and disruptions in sleep and physical activity are common and distressing in gynecologic cancer patients. The aim of our study was to examine whether higher levels of inflammation are associated with worse symptomatology, and if these associations are stronger for patients with gynecologic cancer (n = 121) than age-matched women without a cancer history (i.e., controls; n = 105). Elevated levels of C-reactive protein were associated with depression and disrupted physical activity, but there were no other significant associations between inflammation and treatment-related symptoms. Findings suggest that inflammation may not play a significant role in the development of fatigue or sleep disturbance among gynecologic cancer patients but may contribute to depression and physical inactivity. Previous research suggests that inflammation triggers cancer-treatment-related symptoms (i.e., fatigue, depression, and disruptions in sleep and physical activity), but evidence is mixed. This study examined relationships between inflammatory biomarkers and symptoms in patients with gynecologic cancer compared to age-matched women with no cancer history (i.e., controls). Patients (n = 121) completed assessments before chemotherapy cycles 1, 3, and 6, and 6 and 12 months later. Controls (n = 105) completed assessments at similar timepoints. Changes in inflammation and symptomatology were evaluated using random-effects mixed models, and cross-sectional differences between patients and controls in inflammatory biomarkers and symptoms were evaluated using least squares means. Associations among inflammatory biomarkers and symptoms were evaluated using random-effects fluctuation mixed models. The results indicated that compared to controls, patients typically have higher inflammatory biomarkers (i.e., TNF-alpha, TNFR1, TNFR2, CRP, IL-1ra) and worse fatigue, depression, and sleep (ps < 0.05). Patients reported lower levels of baseline physical activity (p = 0.02) that became more similar to controls over time. Significant associations were observed between CRP, depression, and physical activity (ps < 0.05), but not between inflammation and other symptoms. The results suggest that inflammation may not play a significant role in fatigue or sleep disturbance among gynecologic cancer patients but may contribute to depression and physical inactivity. [ABSTRACT FROM AUTHOR]